Take Lugol’s iodine at night. Iodine is toxic to cancer cells. Start low, build up slowly to at least 50mgs, possibly more. Allow one hour between taking vit C and iodine as they knock each other out (vit C is a reducing agent, iodine is an oxidising agent)

Lugol’s iodine may support cancer therapy by promoting apoptosis and inhibiting cell proliferation, but dosing must be approached cautiously due to its potency. A typical starting dose is 1–2 drops of 5% solution daily, gradually increased under medical supervision.

Scientific Rationale for Cancer Support

Lugol’s iodine, a solution of elemental iodine (I₂) and potassium iodide (KI), has shown promising anti-cancer properties in laboratory studies. It can induce apoptosis (programmed cell death) and inhibit the proliferation of cancer cells by modulating gene expression and disrupting metabolic pathways essential for tumor growth metabolicthe…. These effects are particularly relevant in hormone-sensitive cancers like breast and prostate, where iodine may help regulate estrogen metabolism and reduce oxidative stress.

Mechanisms of Action

• Antiproliferative Effects: Lugol’s iodine has been observed to reduce the growth rate of various cancer cell lines by interfering with DNA synthesis and cell cycle progression metabolicthe….
• Apoptosis Induction: It activates pathways that lead to cell death in abnormal cells, potentially reducing tumor burden.
• Immune Modulation: Iodine may enhance immune surveillance and reduce inflammation, creating a less favorable environment for cancer progression.

These mechanisms are still under investigation, and while preclinical data is encouraging, clinical trials are limited. Therefore, iodine should not be considered a standalone cancer treatment but rather a complementary approach under professional guidance.

Recommended Dosage and Safety

Lugol’s iodine is potent—one drop of 5% solution contains about 6.25 mg of iodine, which is significantly higher than the standard dietary intake of 150 µg/day DoctorMyhill.

Always consult a healthcare provider before starting Lugol’s iodine, especially if you have thyroid conditions, are pregnant, or are undergoing cancer treatment. Would you like help finding clinical studies or practitioner protocols that use iodine in integrative cancer care?

More on Iodine:

David Brownstein explains what he believes are typical findings in people who are deficient in iodine. According to his view, low iodine levels can lead to the development of nodules in important organs, which may progress from early, potentially precancerous changes to more serious disease over time. He describes iodine as playing a key role in maintaining the normal structure of tissues. In its absence, cysts may first appear in areas such as the breasts, ovaries, uterus, thyroid, prostate, and possibly the pancreas. Over time, these cysts can become firmer and more nodular, and with prolonged deficiency, may develop into hyperplastic tissue, which he characterizes as a precursor stage to cancer—what he refers to as an “iodine deficiency continuum.”

He also states that iodine has properties that can promote apoptosis (the programmed death of abnormal cells), suggesting it may help slow or interrupt the uncontrolled growth of cancer cells. In his view, iodine could potentially halt or even reverse this progression, or at least slow it down once it has begun.

It’s worth noting that these claims are debated, and the relationship between iodine levels and cancer development is more complex than presented here, with limited strong clinical evidence supporting some of these conclusions.